Objective. To evaluate a group of 65 adults with a history of or persistent juvenile chronic arthritis (JCA), on average, 26.4 yr after disease onset.
The evaluation of chronic disease on a long-term followdisease outcome and identify disease-related parameters associated with a poor disease outcome. up basis is a central issue. Follow-up studies serve as important tools for the evaluation of the disease process per se and comprise an important quality control tool.
Materials and methods
Furthermore, they provide information which enables the recognition of treatment and disease-associated
The study group problems.
In 1979-1980 Pedersen et al. performed a referral-based In juvenile chronic arthritis (JCA) more than 20 10-yr follow-up study including 93 patients with JCA follow-up studies have been conducted over the past [16 ] . All study participants were admitted to the five decades . Although the early studies may be Hornbaek Hospital of Physical Medicine during the difficult to compare with the more recent ones, due to period [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] and selected according to the EULAR a lack of uniform classification, disease activity and criteria for JCA. Based on a relatively recent assessment disease outcome measures, it is our impression that the of the incidence of JCA in Denmark [24] , Pedersen prognosis for children with JCA/juvenile rheumatoid et al. ' s study group represented approximately 15% of arthritis (JRA) has improved during the 20th century.
the Danish JCA population at the time. The JCA This tendency is consistent with the development of new subtypes at disease onset in the 10-yr follow-up study and possibly better treatment regimens and probably were as follows: 67% of the participants had pauciarticualso to a certain extent due to an improved general lar, 27% had polyarticular and 6% had systemic JCA. health status in the population. Only a few studies have
The male:female ratio was 1:3. followed JCA patients into adulthood.
Participants for the current study were recruited from The objective of the current study was to evaluate a the group previously investigated by Pedersen et had died, one from AIDS and one from septicaemia, was used. Disease duration, meaning years of active disease, was reconstructed from hospital records and four wished to participate but were unable to for various reasons. The rest of the 28 non-participants had either interviews with the patients. Plasma levels of C-reactive protein (CRP), levels of antinuclear antibodies (ANA) left Denmark or did not wish to participate (tired of the 'system', did not like doctors and hated hospitals).
and IgM rheumatoid factor (RF ) were measured in all study participants. One patient was excluded due to Turner's syndrome. Data from the 10-yr follow-up study in [1979] [1980] were Treatment used as baseline data in the current study. The same investigator evaluated all study participants during the The anti-rheumatic drug treatments in the study group were primarily acetylsalicylic acid, gold salts, hydroxyperiod 1996-1997 at the Paediatric Clinic of the Copenhagen University Hospital (Rigshospitalet, chloroquine and systemic and intra-articular steroids. Other disease-modifying anti-rheumatic drugs Denmark). The local ethics committee approved the study and all participants gave their informed consent.
(DMARDs) included penicillamine and only in a few cases methotrexate and sulphasalazine were used.
Disease assessment, outcome measures and laboratory
Thirteen patients had received systemic steroid treatment evaluation >1 yr and 15 patients <1 yr. Non-steroidal antiinflammatory drugs (NSAIDs) were used in the majority Disease status at the time of the study included an evaluation of disease-related parameters assessed by the of patients. Physiotherapy and occupational therapy were given in all cases. However, the paradigm of patient and the investigator. The patient part included a self-reported health assessment questionnaire (HAQ) physiotherapy at the time was passive and active joint maintenance therapy, with as little as possible weight-[25] translated into Danish by one of the investigators and two visual analogue scales ( VAS), one for pain and bearing activity. In other words, the children, while hospitalized, had to put up with a wide range of one for general coping in life with the disease. Based on disease history, joint examination and erythrocyte sedirestrictions and limited physical activity, and a majority of them had to spend most of the day in bed or in a mentation rate ( ESR) ( Westergren method, normal values <15 mm/h for females and <20 mm/h for wheelchair. In some cases treatment with plaster casts and night splints was used. males), the investigator assessed disease activity using the below outlined criteria for remission. Remission was Statistics considered when there were no symptoms or objective signs of active JCA in the presence of normal ESR for Normality was assessed by the Kolmogorov-Smirnov test [27] . A comparison of subgroup means was permore than two consecutive years without any antirheumatic treatment. Joint symptoms due to JCA sequeformed either using the t-test or the non-parametric Mann-Whitney rank sum test in case of non-normality. lae were not considered as evidence of ongoing arthritis. Besides persistent disease activity, the HAQ,
The chi-square test or Fisher's exact test assessed differences in non-paired independent variables. The Steinbrocker functional class [26 ] and history of JCAassociated surgery were used as disease outcome paraMcNemar test was used to calculate differences in pairs of categorical variables. Correlations between disease meters. A HAQ score >0, Steinbrocker functional classes II-IV and history of JCA-related major surgery outcome parameters and disease-associated parameters were calculated using the non-parametric Spearman test were regarded as disease sequelae. In addition, VAS for the physician's overall evaluation of disease activity at [28] . Those of the disease-related parameters most highly correlated to the disease outcome parameters were used the time of the study, based on history and examination, (20) Two participants included in the polyarticular group, one with juvenile spondylarthropathy and one with juvenile psoriatic arthropathy had active disease at the time of the study. 1 represented the HAQ score >0. Steinbrocker functional class I, was coded as 0, while classes II, III and univariate analysis, active disease at the time of the IV were coded as 1. Absence of JCA-related major study was associated with increased HAQ score surgical procedures was coded 0, while presence was (P < 0.001), increased pain VAS (P < 0.001) and coded 1. The level of significance was 5%. The statistical decreased ability to cope in life with arthritis calculations were performed on the 'SPSS' statistics (P < 0.001). VAS for overall disease activity assessment software, version 8.0.
by the physician was increased in the group with active disease (P < 0.001) as was the mean plasma level of CRP. Not surprisingly, those patients who had active Results disease at the time of the study had experienced significCourse of the disease antly longer disease duration (P < 0.001) (see Table 1 ). Thirty patients (46.1%) experienced no pain at the time The mean age (..) at disease onset was 5.7 yr (4.1) and the mean disease duration 12.4 yr (9.5). The disease of the study, of which four had active disease. Univariate analysis showed that long disease duration, nonsubtype distribution at disease onset was as follows: pauciarticular 43 (66.2%), polyarticular 17 (26.1%) and pauciarticular JCA and history of systemic steroid treatment were parameters significantly associated with systemic five (7.7%). Twenty-two (33.8%) of the pauciarticular onset group developed extended pauciarticular increased HAQ (see Tables 4 and 5 ). ANA positivity was present in 30 of the 65 study participants. Of the JCA. One patient had juvenile spondylarthropathy based on the clinical manifestations (was also HLA-B27 pauciarticular group that did not go on to the extended form, 15 (71%) were ANA positive. IgM RF was positive) and one had juvenile psoriatic arthropathy. At the time of the current study 41 (63.1%) patients were elevated in 10 participants, of whom seven had active disease at the time of the study. in remission. Thirteen patients had experienced longlasting remission followed by active JCA, of whom nine JCA-related surgery had extended pauciarticular or polyarticular JCA. Remission was most common in the pauciarticular JCA-related major surgical interventions included: prosthetic hip replacements, femoral head resection, prosgroup, where only four (6.2%) patients had active disease at the time of the study. Persistent disease was mostly thetic knee replacement, leg extension, cervical spine fusion, mandibular correction, arthrodesis of the seen among those patients who had either extended pauciarticular or polyarticular JCA (see Tables 2 and 3). radiocarpal joint, arthrodesis of the first metacarpophalangeal joint and arthrodesis of the foot joint. At the The patient fraction currently in remission did not differ significantly from the 10-yr follow-up study. For time of the 10-yr follow-up study in 1979-1980, three patients (4.6%) had undergone one or more major extended pauciarticular and polyarticular JCA, active disease was present in 11 and eight cases, respectively, surgical procedures associated with JCA. In between the two follow-up studies, an additional 11 patients (17%) which are the same as reported in the 10-yr follow-up. Plasma levels of CRP and ESR were on average only had experienced major surgery. This increase was found to be statistically significant (P < 0.001). Except for one slightly elevated, suggesting a relatively low level of inflammation in the study group as a whole. Disease participant with pauciarticular JCA, the participants who had undergone JCA-related major surgery had characteristics are displayed in Tables 1 and 2 . In extended pauciarticular, polyarticular or systemic JCA.
had taken place during the period between the two follow-up studies. Of the 56 (86%) patients in functional The presence of major surgical interventions was associated with a history of systemic steroid treatment and class I in 1979-1980, 10 had shifted to functional class II and two to functional class III. Two patients had long disease duration (see Tables 4 and 5) .
shifted from functional class III to class IV. Those Functional class patients who were in functional classes II-IV at the time of the current study had experienced a mean disease The Steinbrocker functional class distribution in the study group worsened during the period between the duration of 8.3 yr, unlike those in functional class I who had a mean disease duration of 8.3 yr (P < 0.001). A two follow-up studies (see Fig. 1 ). At the time of the 1979-1980 study, the Steinbrocker functional class disstatistically significant correlation was found between disease duration and Steinbrocker functional class tribution was I/II/III/IV 56/4/3/2. A significant shift from functional class I to functional class II (P = 0.002) (r = 0.68, P < 0.001). Logistic regression with referral-based studies. What in addition complicates the picture is the fact that JCA most likely embraces a Logistic regression analysis was performed to assess the heterogeneous group of diseases where each subtype impact of disease-associated parameters on the disease represents a clinically and prognostically different entity. outcome variables. The disease outcome parameters
In order to assess whether the current study group used in the logistic regression models were dichotomized resembled a true population sample, we compared the HAQ (0 or >0), dichotomized Steinbrocker functional demographic and disease characteristics with previously class in 1996-1997 (class I or II-IV ) and presence or published data from Scandinavia. The study by absence of JCA-related major surgery. Table 6 shows Andersson and Fasth [22, 23] from southwest Sweden the disease-associated parameters that were most was an obvious choice for two reasons. First, the region strongly correlated to the outcome parameters and thus is very close to Denmark and its population very much selected and used as predictors in the logistic regression like the Danish. Second, the study was based on a models. The SPSS 'enter' and 'backward stepwise' representative population sample. In the current study options for logistic regression analysis were used for group there were more patients with extended pauciarticeach of the outcome parameters. The logistic regression ular and polyarticular JCA, a smaller fraction of males, models had an ability to explain between 50 and 85% and a slightly earlier age at disease onset (5.7 vs 7 yr). of the variation in the outcome parameters. In five of
We had to conclude that the demographic and disease the six models, disease duration was the statistically subtype characteristics in the current study group were most significant predictor of the outcome. In addition, different from those of the Swedish study and that our disease subtype other than pauciarticular and history of study group had most likely undergone selection bias. systemic steroid proved to be significant predictors of
The objective of the current investigation was, however, increased HAQ and JCA-related surgery, respectively. not to undertake epidemiological research, but rather to describe functional outcome and residua in a series of Discussion 65 JCA patients 26 yr after disease onset. In a majority of previous follow-up studies, the followMost follow-up studies of JCA/JRA are referral based, up time has ranged between 5 and 15 yr, and only in which implicates interpretation problems due to selecthree studies has exceeded 15 yr for all participants [3, tion bias. The patients included will most likely represent 19, 20] . In two of the later studies, researchers demonthose most in need of hospital care and, therefore, the strated that the fraction of patients with active disease most severe cases and those living closest to the referral was about 30-50% and that the fraction of patients with centres. Those in whom the disease has not yet been disabling residua increased with the follow-up time. identified will for obvious reasons not be included. It is Laaksonen [3] reported 40% with active disease and therefore reasonable to assume that a significant fraction 48% in Steinbrocker functional classes III and IV at the of patients with pauciarticular JCA will never receive a time of a 16-yr follow-up. Levinson 13% of the participants. In contrast, Calabro et al. [10] In the current long-term follow-up study 37% of the participants had active JCA 26 yr after disease onset. reported a more encouraging outcome in a 25-37-yr (mean 25) follow-up published in 1989, where 9% of the We demonstrated that extended pauciarticular and polyarticular subtype was often associated with disease perparticipants had persistent disease activity and 15% were in functional classes III and IV.
sisting into adulthood and that the degree of functional residua-portrayed by a negative shift in functional Except for death, which occurred in two patients (one with systemic JCA, who died aged 23 yr of sepsis and class and the need for surgical intervention-increased with time. Considering the questionable evidence for the one with polyarticular onset JCA who died of AIDS ), disease activity persisting into adulthood is perhaps one efficacy of the treatment received by the current study group, in many respects these patients may represent a of the most important outcome parameters in JCA. We found that 37% of our series had active JCA at the time natural course of the disease. Modern anti-rheumatic treatment regimens may well improve the prognosis for of the 26-yr follow-up, a fraction that had remained unaltered since the 10-yr follow-up study. A vast major-JCA. However, we cannot substantiate clear evidence for that statement prior to new long-term follow-up ity of these participants had either extended pauciarticular or polyarticular disease. This fraction was similar to studies evaluating children who at this moment receive what is considered state of the art JCA treatment. In the 40-45% with active disease found by Laaksonen and Levinson and Wallace [3, 20] . Our observation many respects the observations made in the current study confirm previous findings in long-term follow-up suggests that approximately 10 yr after disease onset a balance is reached, where the fraction of patients with of JCA. persistent disease remains at a more or less constant level. This statement is consistent with the 30-50%
